Youngy Health (300247.SZ) associate company Cinelink Cloud Sharing plans to introduce new shareholder Anhui Yanzhi.

Youngy Health (300247.SZ) announced that, due to the operational development needs of its invested company Anhui Yinglian Yunxiang Medical Technology Co., Ltd. (hereinafter referred to as "Yinglian Yunxiang" or the "target company"), it intends to introduce a new shareholder Anhui Yanzhi Technology Co., Ltd. (hereinafter referred to as the "transferee" or "Anhui Yanzhi") through equity transfer. Anhui Yanzhi has a related relationship with the other shareholders of Yinglian Yunxiang, XUNFEIHEALTH Co., Ltd. (hereinafter referred to as "Xunfei Medical") and Anhui Xunfei Cloud Creation Technology Co., Ltd. (hereinafter referred to as "Xunfei Cloud Creation"). The introduction of the new shareholder Anhui Yanzhi into Yinglian Yunxiang aims to fully leverage its professional advantages in industrial incubation, resource integration, and project operation, to help the target company achieve high-quality development, in line with the fundamental interests of all shareholders including the company. To this end, the target company's other shareholders, who are unrelated to the transferee, intend to transfer part of their equity to Anhui Yanzhi and waive their preemptive rights. Among them, the company and Hefei Yilian Yunxiang Health Management Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Yilian Yunxiang") will transfer 2.8156% and 11.8913% of their respective equity to Anhui Yanzhi in equal proportions (accounting for 41.2% of their respective shareholdings); while another shareholder, Beijing Chong Shan Yuan Wei Investment Center (Limited Partnership), due to the expiration of the fund management term, separately signed a share transfer agreement to transfer all its 6.2786% equity to Anhui Yanzhi. Upon agreement by all parties, the valuation of Yinglian Yunxiang as a whole is calculated at RMB 300 million for the purposes of the equity transfer. The transfer price for the 2.8156% equity transferred by the company is RMB 8.4469 million. After the transaction is completed, the company will continue to hold 4.0176% equity in Yinglian Yunxiang.